Clinical Trials Directory

Trials / Terminated

TerminatedNCT02609451

Closure of Protective Ileostomy 2 vs. 12 Weeks After TME

Closure of Protective Ileostomy 2 vs. 12 Weeks Following Total Mesorectal Excision (TME) for Rectal Surgery: Interim Analysis of a Multicentre, Randomized, Controlled Study

Status
Terminated
Phase
N/A
Study type
Interventional
Enrollment
71 (actual)
Sponsor
Kantonsspital Liestal · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to compare the feasibility, safety, and quality of life (QOL) in patients (pts) undergoing protective ileostomy closure after 2 weeks with a closure after 12 weeks.

Detailed description

In three surgical departments between 2007 and 2013, 72 pts with total mesorectal excision and coloanal or low colorectal anastomosis for rectal cancer were randomly assigned to closure of their protective ileostomy after 2 weeks (group A, 37 pts) or 12 weeks (group B, 35 pts). One day before planned stoma closure, the coloanal/colorectal anastomosis was checked by palpation, contrast enema via ileostomy and, in case of hazards, by proctoscopy. Perioperative data was assessed prospectively using numeric values, visual analogue scales (VAS, 0 = lowest value, 100 = highest value) and QOL-index (GQLI, max. 144 points). Complications were recorded prospectively.

Conditions

Interventions

TypeNameDescription
PROCEDUREIleostomy closureIleostomy closure at a different time point

Timeline

Start date
2007-11-01
Primary completion
2014-03-01
Completion
2014-03-01
First posted
2015-11-20
Last updated
2017-08-31

Locations

1 site across 1 country: Switzerland

Source: ClinicalTrials.gov record NCT02609451. Inclusion in this directory is not an endorsement.